By dcc2012 | August 27, 2021
UBC and BC Cancer researchers have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive.
By jessica allen | May 3, 2021
Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.
By jessica allen | April 22, 2021
Dr. Peter Zandstra explains how the pandemic is shaping biotechnology in B.C., and discusses some of the novel treatments and potential cures for other diseases underway at biotechnology company Notch.